Skip to content

Effect of Group Psychotherapy in Patients With Rheumatoid Arthritis

Effectiveness of Cognitive-Behavioral Group Therapy on Quality of Life in Patients With Rheumatoid Arthritis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017010531711N2
Enrollment
30
Registered
2017-04-05
Start date
2016-04-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis. Seropositive rheumatoid arthritis, Other rheumatoid arthritis

Interventions

Intervention 1: Intervention condition consists of 12 weekly sessions of group cognitive behavioural therapy about 90 minutes each according to manuals of Cognitive Therapy of Chronic Pain and Cogniti
Behavior
Treatment - Drugs
Intervention condition consists of 12 weekly sessions of group cognitive behavioural therapy about 90 minutes each according to manuals of Cognitive Therapy of Chronic Pain and Cognitive-Behavioral In
Control condition consists of standard pharmaceutical care.

Sponsors

Arak University of Medical Sciences, Office of the Vice-chancellor for Research
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Diagnosed with rheumatoid arthritis of at least one year duration by a rheumatologist according to American College of Rheumatology criteria; disease duration of less than 8 years;18 to 65 years for age; female patients; be able to read and write and completed at least 5 grades in elementary school; Disease Activity Score(DAS28) =5.1; Body Mass Index(BMI) 5.1 in follow-up; history of debilitating medical conditions including chronic obstructive pulmonary disease, end stage renal disease, epilepsy, migraine, multiple sclerosis, malignant neoplasms, AIDS, amputated limb and pregnancy; debilitating mental illnesses including major depressive disorder, bipolar mood disorder and psychotic disorders; occurrence of stressful life events including death of a first-degree relative, imprisonment, divorce, addiction, car accident or fire in the course of the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mental Component of Quality of Life. Timepoint: Baseline, After Week 12. Method of measurement: 36-Item Short Form Survey Instrument.;Physical Component of Quality of Life. Timepoint: Baseline, After Week 12. Method of measurement: 36-Item Short Form Survey Instrument.

Secondary

MeasureTime frame
Disability. Timepoint: Baseline, After Week 12. Method of measurement: Health Assessment Questionnaire Disability Index.;Pain. Timepoint: Baseline, After Week 12. Method of measurement: Iranian Short-Form McGill Pain Questionnaire (I-SF-MPQ).;Fatigue. Timepoint: Baseline, After Week 12. Method of measurement: Checklist Individual Strength (CIS).;Depression. Timepoint: Baseline, After Week 12. Method of measurement: Hospital Anxiety and Depression Scale.;Anxiety. Timepoint: Baseline, After Week 12. Method of measurement: Hospital Anxiety and Depression Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNima Tavakoli

Arak University of Medical Sciences

drnimatavakoli@gmail.com+98 86 3313 4717

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026